VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q59678203 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000157.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q59678203‏
024 ‎‡a 0000-0003-0593-7161‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q59678203‏
100 0 ‎‡a Pablo Ramirez‏ ‎‡c researcher ORCID ID = 0000-0003-0593-7161‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Pablo Ramirez‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital‏
670 ‎‡a Author's [Autologous hematopoietic cell transplantation in patients with multiple myeloma. Experience in 53 patients].‏
670 ‎‡a Author's Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis‏
670 ‎‡a Author's Clostridium difficile infection in Chilean patients submitted to hematopoietic stem cell transplantation‏
670 ‎‡a Author's Haploidentical transplantation outcomes are comparable with those obtained with identical human leukocyte antigen allogeneic transplantation in Chilean patients with benign and malignant hemopathies‏
670 ‎‡a Author's Intensity adjustment of hematopoietic alogeneic transplantation in acute leukemia‏
670 ‎‡a Author's [Long term results for intermediate and high grade localized non Hodgkin lymphoma, treated with chemotherapy and radiotherapy]‏
670 ‎‡a Author's Nutritional assessment as predictor of complications after hematopoietic stem cell transplantation‏
670 ‎‡a Author's Outcomes in relapsed Hodgkin's lymphoma treated with autologous and allogeneic hematopoietic cell transplantation at the Pontificia Universidad Católica de Chile‏
670 ‎‡a Author's Response and survival in acute myeloid leukemia patients not candidates to transplantation treated with azacitidine versus palliative treatment: a retrospective study‏
670 ‎‡a Author's Results of acute myeloid leukemia treatment. Analysis of 63 patients between 2010-2014‏
670 ‎‡a Author's [Retrospective study comparing low-dose versus standard dose of bortezomib in patients with multiple myeloma]‏
670 ‎‡a Author's tabibi sabbu‏
670 ‎‡a Author's The CMS experiment at the CERN LHC‏
670 ‎‡a Author's Thrombotic microangiopathy as first manifestation of acute human immunodeficiency virus infection: a case report and review of the literature.‏
670 ‎‡a Author's Treatment of thrombotic thrombocytopenic purpura with rituximab. Report of eight cases‏
670 ‎‡a Author's Umbilical cord hematopoietic precursors transplantation. Report of five patients‏
909 ‎‡a (orcid) 0000000305937161‏ ‎‡9 1‏
912 ‎‡a cmsexperimentatthecernlhc‏ ‎‡A The CMS experiment at the CERN LHC‏ ‎‡9 1‏
912 ‎‡a tabibisabbu‏ ‎‡A tabibi sabbu‏ ‎‡9 1‏
919 ‎‡a thromboticmicroangiopathyas1manifestationofacutehumanimmunodeficiencyvirusinfectionacasereportandreviewoftheliterature‏ ‎‡A Thrombotic microangiopathy as first manifestation of acute human immunodeficiency virus infection: a case report and review of the literature.‏ ‎‡9 1‏
919 ‎‡a retrospectivestudycomparinglowdoseversusstandarddoseofbortezomibinpatientswithmultiplemyeloma‏ ‎‡A [Retrospective study comparing low-dose versus standard dose of bortezomib in patients with multiple myeloma]‏ ‎‡9 1‏
919 ‎‡a resultsofacutemyeloidleukemiatreatmentanalysisof63patientsbetween2010‏ ‎‡A Results of acute myeloid leukemia treatment. Analysis of 63 patients between 2010-2014‏ ‎‡9 1‏
919 ‎‡a responseandsurvivalinacutemyeloidleukemiapatientsnotcandidatestotransplantationtreatedwithazacitidineversuspalliativetreatmentaretrospectivestudy‏ ‎‡A Response and survival in acute myeloid leukemia patients not candidates to transplantation treated with azacitidine versus palliative treatment: a retrospective study‏ ‎‡9 1‏
919 ‎‡a outcomesinrelapsedhodgkinslymphomatreatedwithautologousandallogeneichematopoieticcelltransplantationatthepontificiauniversidadcatolicadechile‏ ‎‡A Outcomes in relapsed Hodgkin's lymphoma treated with autologous and allogeneic hematopoietic cell transplantation at the Pontificia Universidad Católica de Chile‏ ‎‡9 1‏
919 ‎‡a nutritionalassessmentaspredictorofcomplicationsafterhematopoieticstemcelltransplantation‏ ‎‡A Nutritional assessment as predictor of complications after hematopoietic stem cell transplantation‏ ‎‡9 1‏
919 ‎‡a longtermresultsforintermediateandhighgradelocalizednonhodgkinlymphomatreatedwithchemotherapyandradiotherapy‏ ‎‡A [Long term results for intermediate and high grade localized non Hodgkin lymphoma, treated with chemotherapy and radiotherapy]‏ ‎‡9 1‏
919 ‎‡a intensityadjustmentofhematopoieticalogeneictransplantationinacuteleukemia‏ ‎‡A Intensity adjustment of hematopoietic alogeneic transplantation in acute leukemia‏ ‎‡9 1‏
919 ‎‡a haploidenticaltransplantationoutcomesarecomparablewiththoseobtainedwithidenticalhumanleukocyteantigenallogeneictransplantationinchileanpatientswithbenignandmalignanthemopathies‏ ‎‡A Haploidentical transplantation outcomes are comparable with those obtained with identical human leukocyte antigen allogeneic transplantation in Chilean patients with benign and malignant hemopathies‏ ‎‡9 1‏
919 ‎‡a clostridiumdifficileinfectioninchileanpatientssubmittedtohematopoieticstemcelltransplantation‏ ‎‡A Clostridium difficile infection in Chilean patients submitted to hematopoietic stem cell transplantation‏ ‎‡9 1‏
919 ‎‡a bonemarrowstromalcellsmodulatemouseent1activityandprotectleukemiacellsfromcytarabineinducedapoptosis‏ ‎‡A Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis‏ ‎‡9 1‏
919 ‎‡a autologoushematopoieticcelltransplantationinpatientswithmultiplemyelomaexperiencein53patients‏ ‎‡A [Autologous hematopoietic cell transplantation in patients with multiple myeloma. Experience in 53 patients].‏ ‎‡9 1‏
919 ‎‡a admissionofhematopoieticcelltransplantationpatientstotheintensivecareunitatthepontificiauniversidadcatolicadechilehospital‏ ‎‡A Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital‏ ‎‡9 1‏
919 ‎‡a umbilicalcordhematopoieticprecursorstransplantationreportof5patients‏ ‎‡A Umbilical cord hematopoietic precursors transplantation. Report of five patients‏ ‎‡9 1‏
919 ‎‡a treatmentofthromboticthrombocytopenicpurpurawithrituximabreportof8cases‏ ‎‡A Treatment of thrombotic thrombocytopenic purpura with rituximab. Report of eight cases‏ ‎‡9 1‏
943 ‎‡a 201x‏ ‎‡A 2014‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 BLBNB|000286986
996 ‎‡2 BNE|XX1515634
996 ‎‡2 LC|n 2019074298
996 ‎‡2 LC|n 2002018336
996 ‎‡2 BNE|XX1654671
996 ‎‡2 LC|n 2019027800
996 ‎‡2 LC|n 2019032088
996 ‎‡2 SUDOC|197820700
996 ‎‡2 LC|n 97031802
996 ‎‡2 LC|no2024124410
996 ‎‡2 JPG|500333138
996 ‎‡2 ISNI|0000000060726402
996 ‎‡2 SUDOC|175658072
996 ‎‡2 DNB|1112658750
996 ‎‡2 ARBABN|000065732
996 ‎‡2 ARBABN|000065733
996 ‎‡2 ISNI|0000000108870922
996 ‎‡2 LC|n 79143767
996 ‎‡2 ISNI|0000000028287948
996 ‎‡2 DNB|1057524557
996 ‎‡2 BNC|981058516258206706
996 ‎‡2 LC|n 84016149
996 ‎‡2 SUDOC|235305014
996 ‎‡2 LC|n 50054444
996 ‎‡2 LC|no2013027189
996 ‎‡2 NII|DA11470662
996 ‎‡2 DNB|142917508
996 ‎‡2 PTBNP|181945
996 ‎‡2 ISNI|0000000031526786
996 ‎‡2 LC|no2024105712
996 ‎‡2 DNB|1014638682
996 ‎‡2 DNB|1294338102
996 ‎‡2 LC|no2002038885
996 ‎‡2 LC|no 00073957
996 ‎‡2 LC|ns2011001430
996 ‎‡2 SUDOC|140406816
996 ‎‡2 LC|n 2017059669
996 ‎‡2 LC|no2006120666
996 ‎‡2 DNB|1171944039
996 ‎‡2 BNF|17942558
996 ‎‡2 ISNI|0000000360350355
996 ‎‡2 LC|n 2012034547
996 ‎‡2 BNF|14477761
996 ‎‡2 ISNI|0000000408810593
996 ‎‡2 BNE|XX4613368
996 ‎‡2 DNB|132028700
996 ‎‡2 NUKAT|n 2012263031
996 ‎‡2 DNB|136633579
996 ‎‡2 ISNI|000000049891861X
996 ‎‡2 J9U|987007349942905171
996 ‎‡2 CAOONL|ncf11277665
996 ‎‡2 LC|no2009024642
996 ‎‡2 BNF|16230365
996 ‎‡2 LC|no2017053382
996 ‎‡2 BLBNB|000334666
996 ‎‡2 BNF|16698482
996 ‎‡2 NTA|408742305
996 ‎‡2 BNE|XX1125303
996 ‎‡2 SUDOC|240558952
996 ‎‡2 ISNI|0000000081477337
996 ‎‡2 ISNI|0000000116778771
996 ‎‡2 BNE|XX1090839
996 ‎‡2 DNB|1056434082
996 ‎‡2 BNE|XX4829225
996 ‎‡2 BNE|XX6117198
996 ‎‡2 SUDOC|184609380
996 ‎‡2 BNCHL|10000000000000000221786
996 ‎‡2 DNB|1056610514
996 ‎‡2 BNE|XX4841775
996 ‎‡2 ISNI|0000000071648390
996 ‎‡2 ISNI|0000000078784854
996 ‎‡2 ISNI|000000003585543X
996 ‎‡2 LC|n 85812854
996 ‎‡2 SUDOC|181716496
996 ‎‡2 SUDOC|169453405
996 ‎‡2 LC|no2011078026
996 ‎‡2 BNCHL|10000000000000000053444
996 ‎‡2 BNF|15506012
996 ‎‡2 LC|ns2013001109
996 ‎‡2 BNCHL|10000000000000000839110
996 ‎‡2 DNB|137654553
996 ‎‡2 BNF|13924456
996 ‎‡2 BNE|XX903952
996 ‎‡2 LC|no2023123702
996 ‎‡2 SUDOC|095305580
996 ‎‡2 ISNI|0000000081025429
996 ‎‡2 ISNI|0000000041772630
996 ‎‡2 DNB|1167561708
996 ‎‡2 SUDOC|193943018
996 ‎‡2 LC|n 86077701
996 ‎‡2 LC|no2014087352
996 ‎‡2 LC|no2010155792
996 ‎‡2 DNB|1257267523
996 ‎‡2 ISNI|0000000370458087
996 ‎‡2 ISNI|0000000118398801
996 ‎‡2 SUDOC|225614049
996 ‎‡2 LC|nr2001053170
996 ‎‡2 ISNI|0000000061101826
996 ‎‡2 ARBABN|000065717
996 ‎‡2 LC|no2002046337
996 ‎‡2 BNCHL|10000000000000000107994
996 ‎‡2 LC|n 2006067925
996 ‎‡2 BNE|XX4579242
996 ‎‡2 LC|nr2004012845
996 ‎‡2 ISNI|000000049820289X
996 ‎‡2 BNC|981058528481106706
996 ‎‡2 DNB|1051741734
996 ‎‡2 BNCHL|10000000000000000153121
996 ‎‡2 SUDOC|144884410
996 ‎‡2 PTBNP|224390
996 ‎‡2 BNE|XX1085532
996 ‎‡2 ISNI|0000000005021442
996 ‎‡2 DNB|136710042
996 ‎‡2 ISNI|0000000383091181
996 ‎‡2 DNB|1024519848
996 ‎‡2 DNB|132708361
996 ‎‡2 SZ|142917508
996 ‎‡2 LC|no2017157883
996 ‎‡2 ISNI|0000000026848705
996 ‎‡2 NYNYRILM|395230
996 ‎‡2 DNB|1056360631
996 ‎‡2 NKC|stk2008441802
996 ‎‡2 ISNI|0000000054942352
996 ‎‡2 ISNI|0000000081614776
996 ‎‡2 LC|n 2013031345
996 ‎‡2 BNE|XX4416503
996 ‎‡2 BNC|981060409104006706
996 ‎‡2 BNC|981058602752806706
996 ‎‡2 ISNI|0000000070621903
996 ‎‡2 ISNI|0000000110020396
996 ‎‡2 BNE|XX1547712
996 ‎‡2 LC|n 2020226773
996 ‎‡2 LC|no2011083376
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏